Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV zanamivir versus oral oseltamivir in hospitalized adults and adolescents with influenza
2010-021621-12Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zanamivir and oseltamivir in influenza (3 arms), sponsored by GSK. Primary endpoint: Time to clinical response. Started Oct 2010; status: completed.
02
Drugs
zanamiviroseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-021621-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021621-12.